HKSE - Delayed Quote HKD

PAK FAH YEOW (0239.HK)

2.360
+0.020
+(0.85%)
At close: 2:19:05 PM GMT+8
Loading Chart for 0239.HK
  • Previous Close 2.340
  • Open 2.320
  • Bid 2.360 x --
  • Ask 2.380 x --
  • Day's Range 2.310 - 2.360
  • 52 Week Range 2.110 - 2.690
  • Volume 102,500
  • Avg. Volume 89,712
  • Market Cap (intraday) 735.47M
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) 9.08
  • EPS (TTM) 0.260
  • Earnings Date Mar 27, 2025
  • Forward Dividend & Yield 0.07 (2.94%)
  • Ex-Dividend Date Jul 7, 2025
  • 1y Target Est --

Pak Fah Yeow International Limited, an investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name in Hong Kong, Macau, the People's Republic of China, Southeast Asia, North America, the United Kingdom, and internationally. The company operates through three segments: Healthcare, Property Investments, and Treasury Investments. It offers White Flower Embrocation medicated oils, strain relief products, and ointments, as well as Fúzai 239, a floral-scented White Flower Embrocation. In addition, it invests in commercial, industrial, residential, and car park properties and provides advertising agency services. Pak Fah Yeow International Limited was founded in 1927 and is headquartered in Wan Chai, Hong Kong.

www.pakfahyeow.com

106

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0239.HK

View More

Performance Overview: 0239.HK

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0239.HK
4.84%
HANG SENG INDEX (^HSI)
15.20%

1-Year Return

0239.HK
7.78%
HANG SENG INDEX (^HSI)
20.89%

3-Year Return

0239.HK
103.32%
HANG SENG INDEX (^HSI)
16.13%

5-Year Return

0239.HK
18.73%
HANG SENG INDEX (^HSI)
4.43%

Compare To: 0239.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0239.HK

View More

Valuation Measures

As of 5/13/2025
  • Market Cap

    735.47M

  • Enterprise Value

    449.65M

  • Trailing P/E

    9.37

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.10

  • Price/Book (mrq)

    1.00

  • Enterprise Value/Revenue

    1.90

  • Enterprise Value/EBITDA

    4.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    33.12%

  • Return on Assets (ttm)

    9.00%

  • Return on Equity (ttm)

    10.50%

  • Revenue (ttm)

    237.43M

  • Net Income Avi to Common (ttm)

    78.63M

  • Diluted EPS (ttm)

    0.260

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    294.52M

  • Total Debt/Equity (mrq)

    0.57%

  • Levered Free Cash Flow (ttm)

    52.55M

Research Analysis: 0239.HK

View More

People Also Watch